Johannes Schwarz

Johannes Schwarz publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Johannes Schwarz sits on this spectrum.

Johannes Schwarz D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Johannes Schwarz sits on this spectrum.

Best Publications

• Nicotine Activation of α4* Receptors: Sufficient for Reward, Tolerance, and Sensitization

  Andrew R. Tapper;Sheri L. McKinney;Sheri L. McKinney;Sheri L. McKinney;Raad Nashmi;Raad Nashmi;Raad Nashmi;Johannes Schwarz;Johannes Schwarz;Johannes Schwarz

  890
  Citations

• Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group.

  Hani T. S. Benamer;Jim Patterson;Donald G. Grosset;J. Booij

  860
  Citations

• A humanized version of Foxp2 affects cortico-basal ganglia circuits in mice

  Wolfgang Enard;Sabine Gehre;Kurt Hammerschmidt;Sabine M. Hölter

  753
  Citations

• Efficient generation of neural stem cell-like cells from adult human bone marrow stromal cells.

  Andreas Hermann;Regina Gastl;Stefan Liebau;M. Oana Popa

  664
  Citations

• Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder. Comparison with Parkinson's disease and controls.

  I. Eisensehr;R. Linke;S. Noachtar;J. Schwarz

  477
  Citations

• Psychosis pathways converge via D2high dopamine receptors.

  Philip Seeman;Johannes Schwarz;Jiang Fan Chen;Henry Szechtman

  398
  Citations

• Long-term proliferation and dopaminergic differentiation of human mesencephalic neural precursor cells.

  Alexander Storch;Gesine Paul;Marie Csete;Marie Csete;Bernhard O. Boehm

  394
  Citations

• Evolution of microglial activation in patients after ischemic stroke: a [11C](R)-PK11195 PET study.

  Alexander Gerhard;Johannes Schwarz;Ralph Myers;Richard Wise

  362
  Citations

• RGS9 Modulates Dopamine Signaling in the Basal Ganglia

  Zia Rahman;Zia Rahman;Johannes Schwarz;Stephen J. Gold;Stephen J. Gold;Venetia Zachariou

  315
  Citations

• Increased muscle activity during Rapid eye movement sleep correlates with decrease of striatal presynaptic dopamine transporters. IPT and IBZM spect imaging in subclinical and clinically manifest idiopathic REM sleep behavior disorder, Parkinson's disease, and controls

  Ilonka Eisensehr;Reiner Linke;Klaus Tatsch;Bita Kharraz

  310
  Citations

• Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride.

  Angelo Antonini;Johannes Schwarz;Wolfgang H. Oertel;Oliver Pogarell

  289
  Citations

• Pergolide versus levodopa monotherapy in early Parkinson's disease patients: The PELMOPET study

  Wolfgang H. Oertel;Erik Wolters;Cristina Sampaio;Santiago Gimenez‐Roldan

  280
  Citations

• Role of DAT-SPECT in the diagnostic work up of parkinsonism.

  Christoph Scherfler;Johannes Schwarz;Angelo Antonini;Donald Grosset

  274
  Citations

• [11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy.

  A. Gerhard;R. B. Banati;G. B. Goerres;A. Cagnin

  261
  Citations

• [11C]raclopride and positron emission tomography in previously untreated patients with Parkinson's disease Influence of L‐dopa and lisuride therapy on striatal dopamine D2‐receptors

  A. Antonini;J. Schwarz;W. H. Oertel;H. F. Beer

  248
  Citations

• D2 Dopamine Receptors Colocalize Regulator of G-Protein Signaling 9-2 (RGS9-2) via the RGS9 DEP Domain, and RGS9 Knock-Out Mice Develop Dyskinesias Associated with Dopamine Pathways

  Abraham Kovoor;Petra Seyffarth;Jana Ebert;Sami Barghshoon

  246
  Citations

• FTDP-17: an early-onset phenotype with parkinsonism and epileptic seizures caused by a novel mutation.

  Anne D. Sperfeld;Michael B. Collatz;Hartmut Baier;Markus Palmbach

  238
  Citations

• Point mutant mice with hypersensitive α4 nicotinic receptors show dopaminergic deficits and increased anxiety

  Cesar Labarca;Johannes Schwarz;Purnima Deshpande;Sigrid Schwarz

  223
  Citations

• Adherence to antiparkinson medication in a multicenter European study.

  Donald Grosset;Angelo Antonini;Margherita Canesi;Gianni Pezzoli

  217
  Citations

• Dopamine transporter: involvement in selective dopaminergic neurotoxicity and degeneration

  A Storch;A C Ludolph;J Schwarz

  203
  Citations

• Reduced α4β2*–Nicotinic Acetylcholine Receptor Binding and Its Relationship to Mild Cognitive and Depressive Symptoms in Parkinson Disease

  Philipp M. Meyer;Karl Strecker;Kai Kendziorra;Georg Becker

  196
  Citations

• Relationship between clinical features of Parkinson's disease and presynaptic dopamine transporter binding assessed with [123I]IPT and single-photon emission tomography

  K Tatsch;J Schwarz;P D Mozley;R Linke

  187
  Citations